PPI Guided Strategies for Prevention and Treatment of Intraoperative Hypotension

Sponsor
zhiqiang zhou (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05792696
Collaborator
(none)
54
2
6

Study Details

Study Description

Brief Summary

Intraoperative hypotension is closely related to the poor prognosis of surgery. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: PPI guided strategies
  • Behavioral: Empirical strategies
N/A

Detailed Description

Intraoperative hypotension is closely related to the poor prognosis of surgery. Hypotension decreased blood flow perfusion of organs, which lead to dysfunction of multiple organs, especially increasing serious complications such as cardio-cerebrovascular events and acute renal injury within 30 days after surgery. The aim of this study is to establish a set of strategies that can effectively prevent and treat intraoperative hypotension, so as to alleviate possible harm to patients from perioperative hypotension. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia. The lower target mean arterial pressure (MAP) was higher than 65 mmHg. MAP less than 65 mmHg was defined as intraoperative hypotension between induction and tracheal extubation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Peripheral Perfusion Index Guided Strategies for the Prevention and Treatment of Hypotension: a Randomized Trial
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Oct 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: PPI guided strategies

The decision making for prevention and treatment of hypotension was PPI guided to maintain the PPI between 1 and 3.

Behavioral: PPI guided strategies
For targeted MAP or lower, if PPI<1, more fluid therapy. if PPI>3, vasoconstriction therapy. For MAP<65mmHg and 1<=PPI<3, test bolus of 250 ml crystalloid fluid.

Other: conventional strategies

The decision making for prevention and treatment of hypotension dependent on the experience of anesthesiologist.

Behavioral: Empirical strategies
Fluid therapy or vasoconstriction depended on experiences of anesthetic staffs.

Outcome Measures

Primary Outcome Measures

  1. time-weighted average of hypotension (TWA)<65mmHg [Intraoperative (between anesthesia induction and tracheal extubation)]

    total area under MAP<65 mmHg/surgery length

Secondary Outcome Measures

  1. Rate of hypotension after anesthesia induction [from anesthesia induction to 15 minutes after then]

    the number of participants of hypotension/ the number of each group

  2. Cumulative number of intraoperative hypotension episodes [Intraoperative (between anesthesia induction and tracheal extubation)]

    Cumulative number of MAP<65mmHg and last at least for three minutes

  3. Cumulative time of intraoperative hypotension period [Intraoperative (between anesthesia induction and tracheal extubation)]

    Cumulative time of MAP<65mmHg

  4. Proportion of time with hypotension [Intraoperative (between anesthesia induction and tracheal extubation)]

    Proportion of cumulative time of intraoperative hypotension period and the anesthesia time

  5. time-weighted average of hypertension (TWA)>100mmHg [Intraoperative (between anesthesia induction and tracheal extubation)]

    total area under MAP>100 mmHg/surgery length

  6. Cumulative number of intraoperative hypertension episodes [Intraoperative (between anesthesia induction and tracheal extubation)]

    Cumulative number of MAP>100 mmHg and last at least for three minutes

  7. postoperative plasma concentration of lactic acid [5 minutes before and 5 minutes after the end of surgery]

    Plasma concentration of lactic acid in the end of surgery

  8. arterial partial pressure of oxygen (PaO2)/inspired fraction of oxygen (FiO2) [5 minutes before and 5 minutes after the end of surgery]

    PaO2/FiO2

  9. intraoperative urine output [Intraoperative (between anesthesia induction and tracheal extubation)]

    urine output during the surgery

  10. the rate of acute kidney injury (AKI) [within 7 days after the end of surgery]

    the number of participants with AKI/ the number of each group

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

65 years and older ASA Physical Status 1-3 general anesthesia arterial catheterization procedures last more than 2 hours communicate normally in Mandarin

Exclusion Criteria:

abnormal Allen's test higher target than 65 mmHg history of diabetes vascular diseases arrhythmia cardiac function class II and above physical disability, unable to conduct PPI monitoring participated in other clinical studies in the past month

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • zhiqiang zhou

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
zhiqiang zhou, Doctor, Tongji Hospital
ClinicalTrials.gov Identifier:
NCT05792696
Other Study ID Numbers:
  • TJ-IRB20230247
First Posted:
Mar 31, 2023
Last Update Posted:
Mar 31, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by zhiqiang zhou, Doctor, Tongji Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2023